Abstract
Background: The continuing applicability of the Killip classification system to the effective stratification of long‐term and short‐term outcome in patients with acute myocardial infarction (MI) and its influence on treatment strategy calls for reanalysis in the setting of today's primary reperfusion treatments.
Hypothesis: Our study sought to test the hypothesis that Killip classification, established on admission in patients with acute Ml, is an effective tool for early prediction of in‐hospital mortality and long‐term survival.
Methods: A series of 909 consecutive Olmsted County patients admitted with acute MI to St. Marys Hospital, Mayo Clinic, between January 1988 and March 1998 was analyzed. Killip classification was the primary variable. Endpoints were in‐hospital death, major in‐hospital complications, and post‐hospital death.
Results: Patients analyzed included 714 classified as Killip 1,170 classified as Killip II/III, and 25 classified as Killip IV. Increases in in‐hospital mortality and prevalence of in‐hospital complications correspond significantly with advanced Killip class (p < 0.01), with in‐hospital mortality 7% in class I, 17.6% in classes II/III, and 36% in class IV patients (p < 0.001). Killip classification was strongly associated with mode of therapy administered within 24 h of admission (p < 0.01). Killip IV patients underwent primary angioplasty most commonly and were less likely to receive medical therapy.
Conclusions: Killip classification remains a strong independent predictor of in‐hospital mortality and complications, and of long‐term survival. Early primary angioplasty has contributed to a decrease in mortality in Killip IV patients, but effective adjunctive medical therapy is underutilized.
Keywords: acute myocardial infarction, Killip class, reperfusion therapy, in‐hospital mortality, long‐term mortality
Full Text
The Full Text of this article is available as a PDF (851.5 KB).
References
- 1. Killip T, Kimball JT: Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20: 457–464 [DOI] [PubMed] [Google Scholar]
- 2. Rott D, Behar S, Gottlieb S, Boyko V, Hod H: Usefulness of the classification for early risk stratification of patients with acute myocardial infarction in the 1990s compared with those treated in the 1980s. Am J Cardiol 1997; 80: 859–864 [DOI] [PubMed] [Google Scholar]
- 3. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM: Predictors of 30‐day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Circulation 1995; 91: 1659–1668 [DOI] [PubMed] [Google Scholar]
- 4. Becker RC, Burns M, Gore JM, Spencer FA, Ball SP, French W, Lambrew C, Bowlby L, Hilbe J, Rogers WJ: Early assessment and in‐hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: A nationwide perspective of current clinical practice. Am Heart J 1998. May 135:5 Pt 1 786–796 [DOI] [PubMed]
- 5. Launbjerg J, Berning J, Fruergaard P, Eliasen P, Borch‐Johnsen K, Eiken P, Appleyard M: Risk stratification after acute myocardial infarction by means of echocardiographic wall motion scoring and Killip classification. Cardiology 1992; 80: 375–381 [DOI] [PubMed] [Google Scholar]
- 6. Norris RM, Brandt PWT, Caughey DE, Lee A: A new coronary prognostic index. Lancet 1969; 1: 274–278 [DOI] [PubMed] [Google Scholar]
- 7. Norris RM, Lee AJ, Brandt PWT: Mortality in a coronary care unit analysed by a new coronary prognostic index. Lancet 1969; 1: 278–281 [DOI] [PubMed] [Google Scholar]
- 8. Funk M, Pooley‐Richards RL: Predicting hospital mortality in patients with acute myocardial infarction. Am J Crit Care 1994; 3: 168–176 [PubMed] [Google Scholar]
- 9. Chapman BL, Gray CH: Prognostic index for myocardial infarction treated in a coronary care unit. Br Heart J 1973; 35: 135–141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Dubois C, Piérard LA, Albert A, Smeets J‐P, Demoulin J‐C, Boland J, Kulbertus HE: Short‐term risk stratification at admission based on simple clinical data in acute myocardial infarction. Am J Cardiol 1988; 61: 216–219 [DOI] [PubMed] [Google Scholar]
- 11. Piérard LA, Albert A, Chapelle J‐P, Carlier J, Kulbertus HE: Relative prognostic value of clinical, biochemical, echocardiographic and haemodynamic variables in predicting in‐hospital and one‐year cardiac mortality after acute myocardial infarction. Eur Heart J 1989; 10: 24–31 [DOI] [PubMed] [Google Scholar]
- 12. Christiansen JP, Liang C‐S: Reappraisal of the Norris score and the prognostic value of left ventricular ejection fraction measurement for in‐hospital mortality after acute myocardial infarction. Am J Cardiol 1999; 83: 589–591 [DOI] [PubMed] [Google Scholar]
- 13. Scheidt S, Ascheim R, Killip T: Shock after acute myocardial infarction. Am J Cardiol 1970; 26: 556–564 [DOI] [PubMed] [Google Scholar]
- 14. Leor J, Goldbourt U, Reicher‐Reiss H, Kaplinsky E, Behar S, and the Sprint Study Group : Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors and outcome. Am J Med 1993; 94: 265–273 [DOI] [PubMed] [Google Scholar]
- 15. Holmes DR, Bates ER, Kleiman NS, Sadowski Z, Horgan JHS, Morris DC, Califf RM, Berger PB, Topol EJ: Contemporary reperfusion therapy for cardiogenic shock: The GUSTO‐1 Trial experience. J Am Coll Cardiol 1995; 26: 668–674 [DOI] [PubMed] [Google Scholar]
- 16. Berger PB, Holmes DR, Stebbins AL, Bates ER, Califf RM, Topol EJ, for the GUSTO‐1 Investigators : Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded Coronary Arteries (GUSTO‐1) Trial. An observational study. Circulation 1997; 96: 122–127 [DOI] [PubMed] [Google Scholar]
- 17. Lee L, Erbel R, Brown TM, Laufer N, Meyer J, O'Neill W: Multi‐center registry of angioplasty therapy of cardiogenic shock: Initial and long‐term survival. J Am Coll Cardiol 1991; 17: 559–603 [DOI] [PubMed] [Google Scholar]
- 18. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O'Neill WW: Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988; 78: 1345–1351 [DOI] [PubMed] [Google Scholar]
- 19. Disler L, Haitas B, Steingo BJ, McKibbon J: Cardiogenic shock in evolving myocardial infarction: Treatment by angioplasty and streptokinase. Heart Lung 1987; 16: 649–652 [PubMed] [Google Scholar]
- 20. Verna E, Repetto S, Boscarini M, Ghezzi I, Binaghi G: Emergency coronary angioplasty in patients with severe left ventricular dysfunction or cardiogenic shock after acute myocardial infarction. Eur Heart J 1989; 10: 58–66 [DOI] [PubMed] [Google Scholar]
- 21. Hibbard M, Holmes DR, Bailey KR, Reeder GS, Bresnahan JF, Gersh BJ: Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992; 19: 636–649 [DOI] [PubMed] [Google Scholar]
- 22. Itoh T, Fukami K, Oriso S, Umemura J, Nakajima J, Obonai H, Hiramori K: Survival following cardiogenic shock caused by left main coronary artery total occlusion: A case report and review of the literature. Angiology 1997; 48: 163–171 [DOI] [PubMed] [Google Scholar]
- 23. Hochman JS, Boland J, Sleeper JA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H, Menegus MA, Talley JD, McKinlay S, Sandbom T, LeJemtel T, and the SHOCK registry investigators : Current spectrum of cardiogenic shock and the effect of early revascularization on mortality. Circulation 1995; 91: 873–881 [DOI] [PubMed] [Google Scholar]
- 24. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH, for the SHOCK Investigators : Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341: 625–634 [DOI] [PubMed] [Google Scholar]
- 25. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group : Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–322 [PubMed] [Google Scholar]
- 26. Weaver WD, Simes J, Betriu A, Grines CL, Zijstra F, Garcia E, Grinfeld L, Gibbons RJ: Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. A quantitative review. J Am Med Assoc 1997; 278: 2093–2098 [PubMed] [Google Scholar]
- 27. ISIS‐2 (Second International Study of Infarct Survival) Collaborative Group : Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988; 2: 349–360 [PubMed] [Google Scholar]
- 28. Antiplatelet Trialists' Collaboration : Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81–106 [PMC free article] [PubMed] [Google Scholar]
- 29. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM‐Plus) study investigators : Inhibition of the platelet glycoprotein IIB/IIIA receptor with tirofiban in unstable angina and non‐Q wave myocardial infarction. N Engl J Med 1998; 338: 1488–1497 [DOI] [PubMed] [Google Scholar]
- 30. Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F: A comparison of low‐molecular‐weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non‐Q‐wave coronary events study group. N Engl J Med 1997; 337: 447–452 [DOI] [PubMed] [Google Scholar]
- 31. Gottlieb SS, McCarter RJ, Vogel RA: Effect of beta‐blocker on mortality among high risk and low risk patients after myocardial infarction. N Engl J Med 1998; 339: 489–497 [DOI] [PubMed] [Google Scholar]
- 32. ISIS‐4 Collaborative Group . ISIS‐4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–685 [PubMed] [Google Scholar]
- 33. The GISSI‐3 Study Group : GISSI‐3: Effects of lisinopril and transdermal glycerol trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115–1122 [PubMed] [Google Scholar]
- 34. Dries DL, Solomon AJ, Gersh BJ: Adjunctive therapy after reperfusion therapy in acute myocardial infarction. Clin Cardiol 1998; 21: 379–386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE: WHO criteria for diagnosis of acute myocardial infarction. Am Heart J 1984; 108: 150–158 [DOI] [PubMed] [Google Scholar]
- 36. Rott D, Behar S, Gottlieb S, Boyko V, Hod H: Does Killip classification still work in the thrombolytic era? Cardiol Rev 1998; 8: 22–25 [Google Scholar]
- 37. Rollag A, Mangschau A, Jonsbu J, Aase O, Nerdrum HF, Erikssen J: Do x‐ray determined cardiac volume and signs of congestive heart failure provide additional prognostic information after myocardial infarction if the left ventricular ejection fraction is known? J Intern Med 1989; 225: 267–272 [DOI] [PubMed] [Google Scholar]
- 38. Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH: Early discharge in the thrombolytic era: An analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t‐PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol 1996; 27: 625–632 [DOI] [PubMed] [Google Scholar]